ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Everest Medicines (1952.HK)
Everest Medicines share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$27.94▼ -3.99%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
44%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Everest Medicines in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Everest Medicines
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Everest Medicines a 44% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between HK$22.45 and HK$32.14; in 9 out of 10, between HK$16.33 and HK$44.18. Estimated annual volatility is 112%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$12.6B
- Market cap (USD)
- $1.6B
- 52-week high
- HK$51.20
- 52-week low
- HK$22.70
- Revenue (12 months)
- CN¥2.4B
- Gross margin
- 69.8%
- Operating margin
- -2.8%
- Net margin
- -2.2%
- Beta
- 1.54
What this means
ATLAS does not publish a fair value for 1952.HK right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks 1952.HK has traded between HK$22.70 and HK$51.20. Today it is 45.4% below that high and 23% above its low.
Its beta is 1.54: it tends to move more than the market, both up and down.
About the company
Everest Medicines Limited, a biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
Want to see everything about Everest Medicines?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Everest Medicines do?
Everest Medicines Limited, a biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
What is the chance 1952.HK goes up next month?
44%: somewhat worse than a coin flip. In half of the simulated outcomes, 1952.HK ends the month between HK$22.45 and HK$32.14.
How big is Everest Medicines and what is its P/E ratio?
Everest Medicines's market capitalization is HK$12.6B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 1952.HK?
ATLAS estimates annual volatility at 112%. In a typical month, half of the outcomes end between HK$22.45 and HK$32.14.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer